Nanosculpting reversed wavelength sensitivity into a photoswitchable iGluR

Department of Molecular and Cell Biology, University of California, Berkeley, CA 94720, USA.
Proceedings of the National Academy of Sciences (Impact Factor: 9.67). 05/2009; 106(16):6814-9. DOI: 10.1073/pnas.0811899106
Source: PubMed


Photoswitched tethered ligands (PTLs) can be used to remotely control protein function with light. We have studied the geometric and conformational factors that determine the efficacy of PTL gating in the ionotropic glutamate receptor iGluR6 using a family of photoiosomerizable MAG (maleimide-azobenzene-glutamate) PTLs that covalently attach to the clamshell ligand-binding domain. Experiments and molecular dynamics simulations of the modified proteins show that optical switching depends on 2 factors: (i) the relative occupancy of the binding pocket in the 2 photoisomers of MAG and (ii) the degree of clamshell closure that is possible given the disposition of the MAG linker. A synthesized short version of MAG turns the channel on in either the cis or trans state, depending on the point of attachment. This yin/yang optical control makes it possible for 1 wavelength of light to elicit action potentials in one set of neurons, while deexciting a second set of neurons in the same preparation, whereas a second wavelength has the opposite effect. The ability to generate opposite responses with a single PTL and 2 versions of a target channel, which can be expressed in different cell types, paves the way for engineering opponency in neurons that mediate opposing functions.

Download full-text


Available from: Pau Gorostiza, Mar 17, 2014
30 Reads
  • Source
    • "The second objective was to determine whether substitution at any of the carbon atoms of 2-AEMP preserves significant activity of the compound at GABA A -␳1 receptors. This question is of interest for potential neurobiology applications in which a chainderivatized form of this type of GABA analog could be tethered to an anchoring surface via, for instance, streptavidin (Saifuddin et al., 2003; Nehilla et al., 2004; Vu et al., 2005), to a nanoparticle (Gussin et al., 2006), or to the receptor itself (Volgraf et al., 2006; Numano et al., 2009). 2-AEMP derivatives are relatively easy to prepare, and the key building blocks, phosphonic acids and 2-aminoalcohols, are readily available. "
    [Show abstract] [Hide abstract]
    ABSTRACT: 2-Aminoethyl methylphosphonate (2-AEMP), an analog of GABA, has been found to exhibit antagonist activity at GABA(A)-ρ1 (also known as ρ1 GABA(C)) receptors. The present study was undertaken to elucidate 2-AEMP's action and to test the activities of 2-AEMP analogs. Whole-cell patch-clamp techniques were used to record membrane currents in neuroblastoma cells stably transfected with human GABA(A)-ρ1 receptors. The action of 2-AEMP was compared with that of 1,2,5,6-tetrahydropyridin-4-yl methylphosphinic acid (TPMPA), a commonly used GABA(A)-ρ1 antagonist. With 10 μM GABA, 2-AEMP's IC(50) (18 μM) differed by less than 2.5-fold from that of TPMPA (7 μM), and results obtained were consistent with a primarily competitive mode of inhibition by 2-AEMP. Terminating the presentation of 2-AEMP or TPMPA in the presence of GABA produced a release from inhibition. However, the rate of inhibition release upon the termination of 2-AEMP considerably exceeded that determined with termination of TPMPA. Moreover, when presented at concentrations near their respective IC(50) values, the preincubation period associated with 2-AEMP's onset of inhibition was much shorter than that for TPMPA. Analogs of 2-AEMP possessing a benzyl or n-butyl rather than a methyl substituent at the phosphorus atom, as well as analogs bearing a C-methyl substituent on the aminoethyl side chain, exhibited reduced potency relative to 2-AEMP. Of these analogs, only (R)-2-aminopropyl methylphosphonate significantly diminished the response to 10 μM GABA. Structure-activity relationships are discussed in the context of molecular modeling of ligand binding to the antagonist binding site of the GABA(A)-ρ1 receptor.
    Molecular pharmacology 08/2011; 80(6):965-78. DOI:10.1124/mol.111.071225 · 4.13 Impact Factor
  • Source
    • "DREADD ligands can be administered at different time courses throughout drug behavioral paradigms to parcel out the selective role of signaling receptors in the two MSNs in drug models. Optogenetic tools in particular provide an extremely powerful means to temporally regulate not only neuronal activity but G-protein-coupled receptor signaling using OptoXRs (Airan et al., 2009), glutamatergic signaling(Volgraf et al., 2006; Numano et al., 2009), GABAergic signaling, and even certain intracellular signaling molecules (Wu et al., 2009; Hahn and Kuhlman, 2010). Ultimately, it may be possible to extend these capabilities to optogenetic regulation of transcriptional activity. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The striatum plays a key role in mediating the acute and chronic effects of addictive drugs, with drugs of abuse causing long-lasting molecular and cellular alterations in both dorsal striatum and nucleus accumbens (ventral striatum). Despite the wealth of research on the biological actions of abused drugs in striatum, until recently, the distinct roles of the striatum's two major subtypes of medium spiny neurons (MSNs) in drug addiction remained elusive. Recent advances in cell-type-specific technologies, including fluorescent reporter mice, transgenic, or knockout mice, and viral-mediated gene transfer, have advanced the field toward a more comprehensive understanding of the two MSN subtypes in the long-term actions of drugs of abuse. Here we review progress in defining the distinct molecular and functional contributions of the two MSN subtypes in mediating addiction.
    Frontiers in Neuroanatomy 07/2011; 5:41. DOI:10.3389/fnana.2011.00041 · 3.54 Impact Factor
  • Source
    • "Photoswitching of enzymatic activity has been achieved by attaching 10 photoswitchable groups (PSG e.g. azobenzenes, flavonoids, pyrans, terpenoids etc.) to enzyme, cofactor or inhibitor (Harvey and Abell, 2001; Füllbeck et al., 2006; Numano et al., 2009; Weston et al., 1999; Hosaka et al., 1994; Kim et al., 2009). Photoreversible Antigen-Antibody reactions have also been investigated experimentally (Hosaka et al., 1994). "
    [Show abstract] [Hide abstract]
    ABSTRACT: This paper presents theoretical and simulation studies on controlling enzymatic reactions with photoswitchable inhibitors. It is found that the maximum attainable switching ratio (ratio of the steady state rates of product formation in the "on" and the "off" state) of a photoswitchable inhibitor is dependent on its photoswitching factor (ratio of the equilibrium constants of the photostationary states under the "off" and the "on" illuminations). Attachment of multiple photoswitchable groups to an inhibitor molecule increases the theoretically attainable switching ratio. The affinity of the enzyme for the substrate and the inhibitor is the rate-limiting factor of the switching between active and inactive states. Use of inhibitors with high enzyme affinity and photoswitchable groups with high photoswitching factor would provide high switching ratio. These results may help to design better systems for optical control of biochemical processes.
    Interdisciplinary Sciences Computational Life Sciences 06/2011; 3(2):79-90. DOI:10.1007/s12539-011-0063-z · 0.66 Impact Factor
Show more